(c) 2024 PillSync.com

Guanfacine 1 MG Oral Tablet

INDICATIONS AND USAGE Guanfacine tablets, USP are indicated in the management of hypertension. Guanfacine tablets, USP may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.

Actavis Pharma, Inc.

FDA Reported Adverse Reactions
[1] drug dependence    [2] pain    [3] drug ineffective    [4] overdose    [5] death    [6] toxicity to various agents    [7] dyspnoea    [8] emotional distress    [9] off label use    [10] fatigue   

4 years ago ROUND PINK WATSON 444 Guanfacine 1 MG Oral Tablet

ROUND PINK WATSON 444

4 years ago ROUND PINK WATSON 444 Guanfacine 1 MG Oral Tablet

WATSON 444 ROUND PINK

HOW SUPPLIED

GUANFACINE tablets, USP are available in the following dosing strengths (expressed in equivalent amounts of

GUANFACINE):

GUANFACINE tablets, USP 1 mg, are pink, round tablets, debossed with WATSON 444 on one side and plain on the other side and are available in bottles of 100 (NDC 0591-0444-01).

GUANFACINE tablets, USP 2 mg, are peach, round tablets, debossed with WATSON 453 on one side and plain on the other side and are available in bottles of 100 (NDC 0591-0453-01). Bottles of 100 tablets are supplied with child-resistant closures. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container. Manufactured In India By: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Manufactured For: Teva Pharmaceuticals Parsippany, NJ 07054 Rev. A 10/2023


More pills like ROUND WATSON 444

Related Pills

Guanfacine 1 MG Oral Tablet

actavis pharma, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site